Introduction
One of the major risks in the pregnancy of a diabetic women is the higher prevalence of neonatal problems. In the newborn period hypoglycemia, visceromegaly, polycythemia,hyperbilirubinemia and a characteristic aspect can be typical features of children of diabetic mothers, and their perinatal morbidity and mortality is significantly increased [4, 6] . Modern management of pregnant diabetic women tries to reach normoglycemia which ideally should be achieved before conception but at least immediately after the diagnosis of pregnancy [5, 10] . It has been shown that normoglycemia for the full length of pregnancy can be achieved [1] under optimal circumstances with continuous modifications of the insulin dose based on daily measurements of the blood glucose levels by the trained patient and biweekly controls by the physician. Glycosylated hemoglobin (HbAl) serves as a parameter for long-term assessment of the mean blood glucose, but its value is limited by the fact that during pregnancy an increased number of young erythrocytes are released resulting in false low measurements [2] . WEISS [12] was the first to emphasize the importance of an insulin determination in amniotic fluid for the management of diabetes in preg- nancy. Because of the long half-life of insulin in amniotic fluid a measurement of this parameter can be considered another index for the longterm diabetic control, and the same applies for C-peptide which is formed in equimolar amounts with insulin during the proteolytic cleavage of proinsulin [3] . Our study was designed to determine which of the three parameters (HbAl, amniotic fluid insulin or C-peptide) has the best prognostic power with regard to neonatal problems due to maternal diabetes. . The values were assessed following the curves described HbAl-concentrations were measured biweekly before [3] Thefe were no com pii ca tions from in 57 pregnant diabetic women, 2 of which the amnioce nteses. For counselling purposes we belonged to White's class A, 24 were class Β used & risk f of Q 3 o /0 [7] 12 class C and in 19 patients the severity of diabetes was class D (n = 15) or more (n = 4). The newborns were evaluated routinely by the We used the micr column method (PanChem, pediatricians according to their clinical presenKleinwallstadt, FRG) because its handling is tation and glucose requirements post partum. simple and the results obtained correlate well The minimum requirements for classifying a with the HbAlc-determination according to the child as having "major symptoms" were hypomethod of TRIVELLI [11] . Mean values were glycemia of less than 30mg% for more than 7 calculated from the measurements between the days and body weight above the 90th percentile. 30th and 40th week of pregnancy, and in those Most of these children had visceromegaly and/ patients in whom only a few values could be or hyperbilirubinemia, some exhibited increasobtained because of late registration.
ed hematocrit values, cardiomyopathy or hypo-' , , , , calcemia. One child suffered from respiratory For normal control values we used the measure-distress drome Minor alterati ons in blood ments in 72 non-diabetic patients after the 30th e leydg which coul(J be controlled b week of pregnancy. In those patients a routine f nt meals were not considered oral glucose tolerance test was performed and venous blood was obtained at the same time for HbAl-determination. Only HbAl values in those patients were used whose 100 g glucose 3 Results tolerance test was not pathologic according to The mean yalue of H bΑΙ-measurements of the criteria of Ο SULLIVAN [9 . The HbAl meas-thoge ^ who had normal m oQTT û rements were performed between the 30th and ^ + " ^ Qm ^ For e * aluation of 40th week of pregnancy and up to three days the -insulin and C -peptide levels in the alter delivery.
34th _ 3?th pregnancy weeks those values were The present study includes pregnancies in which considered normal which corresponded to the an amniocentesis between the 34th and 37th 99th percentile of a distribution derived from week was consented to by the patient. This the concentration of these peptides in 275 nonconstitutes about 52% of the total number of diabetic pregnancies. These limits were found diabetic pregnancies in our center during the to be 23 μυ/ml insulin and 3 ng/ml C-peptide observation period from 1981 -1984. Using (table I) . The cut-off points of 18 μΐΐ/ml insulin commercially available test kits we measured and 2.6 ng/ml C-peptide used in tables II and amniotic fluid insulin (Serono, Freiburg, FRG) Ilia, b are derived from the mean values of 3/ 5 insulin above 18 μυ/ml and C-peptide above 3 ng/ml 4/ 7 insulin above 18 μυ/ml, C-peptide above 3 ng/ml 60% 57% and HbAl above 7.5% insulin above 23 μυ/ml, C-peptide above 3 ng/ml and HbAl above 7.5% 2 of 3 parameters above limit (18 μυ/ml, 3 ng/ml, 7.5%) Nine of the 57 children whose mothers had a determination of glycosylated hemoglobin and an amniocentesis, had major neonatal complications. The mean glucose application in those children during the first 24 hours was 7.8 mg/ kg body weight/minute as opposed to 4.2 mg in healthy children of diabetic mothers. Table I indicates that 75-96% of the children without neonatal symptomatology had normal values of one of the three parameters, depending on the cut-off points chosen. The narrower the normal range is defined, the lower is the number of children with normal values. If the insulin cut-off point is lowered from 23 to 18 μΐΐ/ml, the percentage of children with normal values of amniotic fluid insulin decreases from 96 to 83%. C-peptide shows a similar decrease of normal values in non-symptomatic patients from 88 to 75%. The rate of values measured correctly as elevated increases from 56 to 78% in the case of insulin.
Discussion
In the case of C-peptide the introduction of a lower limit increases the rate of false low values, the rate of correctly or falsely increased values remains unchanged. We conclude from our data that the upper limits of the three parameters should be 7.5% for HbAl, 18 μΠ/ml for amniotic fluid insulin and 3.0 ng/ml for C-peptide. When trying to derive a prognosis from these elevated values and to test the predictive value of all three parameters, the results in table II have to be considered. It is obvious that the prediction of a healthy baby is easy. Depending on the parameter chosen a correct prediction can be expected in 83 to 95% of all cases. The determination of amniotic fluid insulin is associated with a predictive value based on an upper limit of 18 μυ/ml. The prediction of newborn morbidity can also be achieved using the same criteria. For this purpose the determination of amniotic fluid insulin is most useful with values higher than 23 μυ/ml being clearly pathologic. The determination of C-peptide and HbAl is less useful but values higher than 9% HbAl can be considered pathologic in 44% of the cases. Taking into account more than one single parameter, the accuracy of the prediction "healthy child" reaches 100% (table Ilia, b). The accuracy of the prediction of major neonatal problems cannot be further increased, it ranges between 54 and 66% if all three parameters are assessed simultaneously. It should be taken into account that the significance of the results is limited due to the sample size.
According to our results the concentration of insulin in amniotic fluid is the most reliable parameter for the evaluation of developing fetal impairment. This is in contrast to LIN et al [8] , who found C-peptide to be more reliable. It is obvious that a statement can be made with much higher certainty when the other parameters are also taken into account. For the exclusion of severe neonatal disease HbAl, amniotic fluid insulin and C-peptide have to be lower than 7.5%, 18 μυ/ml and 3.0 ng/ml respectively. If two of these three parameters are below these limits, a fetal impairment can be excluded with more than 90% certainty.
An amniotic fluid insulin level of more than 23 μΠ/ηιΙ can be considered as a strong indicator of neonatal disease. The accuracy of this prediction is more than 70%. An increase of the insulin level to more than 18 μυ/ml has to be evaluated by taking the other parameters into account: A fetal compromise has to be assumed in more than 60% of the cases if all three values are increased. If only two values* are elevated, the accuracy of the prediction is lowered to about 50%.
Summary
The predictive value of three parameters (amniotic fluid insulin and C-peptide, and HbAl) in prognosticating major neonatal symptomatology was investigated in 57 pregnancies of diabetic women. The prediction of a healthy neonate can be achieved with a 90% accuracy by measurement of the amniotic fluid insulin alone. The correct prognosis for a child with major neonatal problems due to maternal diabetes can be made with 70% certainty using the same method. All other parameters can be judged less valuable based on our results. By using more than one of those parameters mentioned, the prediction of a healthy child can be made more correctly with a certainty of almost 100%. The accuracy in predicting a child with major symptoms cannot be increased any further.
Keywords: Amniotic fluid C-peptide, amniotic fluid insulin, HbAl, infants of diabetic mothers. On a explore la valeur predictive de trois parametres (insuline dans le liquide amniotique, peptide C et Hb Al) face ä la Symptomatologie neonatale majeure au cours de 57 grossesses chez des femmes diabetiques. On peut prevoir un nouveau-ne en bonne sante avec une fiabilite de 90% en determinant uniquement I'insuline dans le liquide amniotique. La prevision correcte d'un enfant qui presentera des problemes neonataux majeurs secondaires au diabete maternel est possible avec une fiabilite de 70% en utilisant la meme methode. En se fondant sur nos resultats, on peut juger tous les autres parametres comme moins valables. En utilisant plus d'un des parametres meiitionnes, on peut predire correctement un enfant en bonne sante avec une fiabilite proche de 100%. Toutefois, la fiabilite de la prevision d'un enfant qui presentera des symptomes majeurs, ne peut pas etre augmente de la sorte.
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